<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The ocular prognosis of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease was assessed in 31 French native patients with ocular involvement </plain></SENT>
<SENT sid="1" pm="."><plain>The mean follow-up time was 6 years </plain></SENT>
<SENT sid="2" pm="."><plain>Ophthalmologic manifestations revealed the disease in 61% of patients, and it was the first symptom in 29% </plain></SENT>
<SENT sid="3" pm="."><plain>Two groups of patients could be identified: the minor forms (23%) which remained stable with <z:chebi fb="0" ids="23359">colchicine</z:chebi> alone and the severe forms (77%) which required steroid (32%) and/or immunosuppressive (45%) therapy </plain></SENT>
<SENT sid="4" pm="."><plain>In the severe forms, 32 eyes were unchanged, 4 eyes showed improvement, and 12 eyes showed deterioration in visual acuity </plain></SENT>
<SENT sid="5" pm="."><plain>Positivity of HLA B5, sex and complete form of the disease were not predictive factors of ocular involvement, or of its seriousness </plain></SENT>
<SENT sid="6" pm="."><plain>At 6 years, 16% of the eyes (versus 14% at the beginning) had a visual acuity less than 1/10, and 71% (versus 74% at the beginning) had a visual acuity greater than 8/10 </plain></SENT>
<SENT sid="7" pm="."><plain>A close collaboration between ophthalmologists and internists allows a good visual prognosis in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>